chr2-3550458-C-T
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_002936.6(RNASEH1):c.424G>A(p.Val142Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000174 in 1,612,902 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_002936.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNASEH1 | ENST00000315212.4 | c.424G>A | p.Val142Ile | missense_variant | Exon 4 of 8 | 1 | NM_002936.6 | ENSP00000313350.3 | ||
ENSG00000286905 | ENST00000658393.1 | n.424G>A | non_coding_transcript_exon_variant | Exon 4 of 12 | ENSP00000499330.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152062Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251392Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135878
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1460840Hom.: 1 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 726750
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152062Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74266
ClinVar
Submissions by phenotype
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2 Pathogenic:3
The missense variant p.V142I in RNASEH1 (NM_002936.6) has been previously reported in affected indviduals. Functional studies reveal a damaging effect (Reyes et al,2016). The variant has been submitted to ClinVar as Pathogenic. The p.V142I variant is observed in 6/34,588 (0.0173%) alleles from individuals of Latino background in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The p.V142I missense variant is predicted to be damaging by both SIFT and PolyPhen2. The valine residue at codon 142 of RNASEH1 is conserved in all mammalian species. The nucleotide c.424 in RNASEH1 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. -
- -
- -
not provided Pathogenic:2
This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 142 of the RNASEH1 protein (p.Val142Ile). This variant is present in population databases (rs766294940, gnomAD 0.02%). This missense change has been observed in individuals with chronic progressive external ophthalmoplegia with mitochondrial DNA deletions (PMID: 26094573, 28508084). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 372197). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RNASEH1 protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
Published functional studies demonstrate that the V142I variant damages the mitochondria and significantly impairs the function of RNASEH1 with approximately 60% decreased activity compared to wild-type (PMID: 26094573, 27402764); This variant is associated with the following publications: (PMID: 31178343, 26094573, 28508084, 26968897, 27402764, 30340744, 31271879, 33726816, 35711919) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at